ArticleJournal of Korean medical science2026
Real-World Outcomes of Tisagenlecleucel Versus Standard-of-Care Salvage Chemotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis From Korea.
Seonggyu Byeon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.